International Stem Cell Corporation , a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the Court of Justice of the European Union , the European Union's highest court, has ruled in favor of the Company and that the Company's core technology patent applications are not covered by the prohibition on patenting embryonic stem cells. This ruling confirms the opinion of the Advocate General published in July 2014.
http://ift.tt/13gyWlA
http://ift.tt/13gyWlA
No comments:
Post a Comment